CLOSE X

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1760.50-17.75 (-1 %)
PREV CLOSE ( ) 1778.25
OPEN PRICE ( ) 1775.10
BID PRICE (QTY) 1759.30 (2)
OFFER PRICE (QTY) 1760.40 (42)
VOLUME 89458
TODAY'S LOW / HIGH ( )1720.80 1775.10
52 WK LOW / HIGH ( )1583.6 2047.55
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Dilip Shantilal Shanghvi - Chairman Kirti Ganorkar - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja, ,
Vadodara,
Gujarat-390012

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
30Oct Sun Pharma gets USFDA’s nod for supple
Sun Pharmaceutical Industries has received the U.S. Food and Drug Admini..
30Oct Sun Pharma shines on getting USFDA’s n
Sun Pharmaceutical Industries is currently trading at Rs. 1795.05, up by..
30Oct Sun Pharma’s consolidated net profit f
Sun Pharmaceutical Industries has reported results for the second quarte..
26Oct Sun Pharmaceutical Industries informs
Further to earlier communication dated 12 October 2026, Sun Pharmaceutic..
13Oct Sun Pharma gets nod to raise up to Rs
Sun Pharmaceutical Industries (Sun Pharma) has received approval for the..
Financials
Rs. in Millions
QTR Sep 26 ANNUAL 26
Net Profit8712.926234.2
Gross Profit 12029.9 37941.2
Operating Profit 17957.466000.2
Net Sales 61419.2207546.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Divi's Laboratories (BSE)
 9941.00 (2.33%)
M.Cap ( in Cr)264300.52
Abbott India (BSE)
 25810.00 (0.85%)
M.Cap ( in Cr)54848.70
Sanofi India (BSE)
 3341.80 (4.29%)
M.Cap ( in Cr)7676.11
Haleos Labs (BSE)
 1456.00 (7.12%)
M.Cap ( in Cr)440.19
Sanofi Cons. Health (BSE)
 3524.90 (2.62%)
M.Cap ( in Cr)8116.91
Shareholding Pattern
PROMOTERS 52.68%
MUTUAL FUNDS/UTI 13.01%
NON-INSTITUTION 10.7%
FI/BANKS/INSURANCE 6.85%
GOVERNMENT 0%
FII 0%
Advisory for Investors Complaints Data September 2026 Broking Complaints Data September 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002
  • 6)Verified UPI ID for receiving Payments: badjate.rzp1.brk@validhdfc
  • 7)Click here for QR Code

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES| SEBI PRESENTS SAMAJH SE INVESTING SIMPLE

© Badjate Group 2018

Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.